147284-80-8

Basic information

• Product Name: 4-Morpholineacetamide, N-[1-[2-[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3,3-trifluoro-1-(1-meth ylethyl)propyl]amino]-2-oxoethyl]-1,2-dihydro-2-oxo-6-phenyl-3-pyridinyl] -
• CAS NO: 147284-80-8
• Molecular Formula: C31H45F3N4O5Si
• Molecular Weight: 638.803
• Mol File: 147284-80-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Morpholineacetamide, N-[1-[2-[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3,3-trifluoro-1-(1-meth ylethyl)propyl]amino]-2-oxoethyl]-1,2-dihydro-2-oxo-6-phenyl-3-pyridinyl] -(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Morpholineacetamide, N-[1-[2-[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3,3-trifluoro-1-(1-meth ylethyl)propyl]amino]-2-oxoethyl]-1,2-dihydro-2-oxo-6-phenyl-3-pyridinyl] -(147284-80-8)
• EPA Substance Registry System: 4-Morpholineacetamide, N-[1-[2-[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3,3-trifluoro-1-(1-meth ylethyl)propyl]amino]-2-oxoethyl]-1,2-dihydro-2-oxo-6-phenyl-3-pyridinyl] -(147284-80-8)

Safety Data

• Hazardous Substances Data: 147284-80-8(Hazardous Substances Data)

Upstream product

• 147269-02-1 2-<3-<(benzyloxycarbonyl)amino>-2-oxo-6-phenyl-1,2-dihydro-1-pyridyl>-N-<2-<(tert-butyldimethylsilyl)oxy>-3,3,3-trifluoro-1-isopropylpropyl>acetamide 
• 3235-69-6 morpholin-4-ylacetic acid 
• 147283-34-9 2-(3-amino-2-oxo-6-phenyl-1,2-dihydro-1-pyridyl)-N-<2-<(tert-butyldimethylsilyl)oxy>-3,3,3-trifluoro-1-isopropylpropyl>acetamide 

Downstream Products

• 147284-84-2 2-[3-(2-Morpholin-4-yl-acetylamino)-2-oxo-6-phenyl-2H-pyridin-1-yl]-N-(3,3,3-trifluoro-2-hydroxy-1-isopropyl-propyl)-acetamide 

Relevant articles and documents

Nonpeptidic Inhibitors of Human Leukocyte Elastase. 3. Design, Synthesis, X-ray Crystallographic Analysis, and Structure-Activity Relationships for a Series of Orally Active 3-Amino-6-phenylpyridin-2-one Trifluoromethyl Ketones

A series of nonpeptidic inhibitors of human leukocyte elastase (HLE) is reported.These trifluoromethyl ketone-based inhibitors contain a 3-amino-6-phenylpyridone group as a central template.The effect of varying the N-3 substituent in these inhibitors on